Literature DB >> 26301048

Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Georgios I Tsiaoussis1, Stelios F Assimakopoulos1, Athanassios C Tsamandas1, Christos K Triantos1, Konstantinos C Thomopoulos1.   

Abstract

The intestinal lumen is a host place for a wide range of microbiota and sets a unique interplay between local immune system, inflammatory cells and intestinal epithelium, forming a physical barrier against microbial invaders and toxins. Bacterial translocation is the migration of viable or nonviable microorganisms or their pathogen-associated molecular patterns, such as lipopolysaccharide, from the gut lumen to the mesenteric lymph nodes, systemic circulation and other normally sterile extraintestinal sites. A series of studies have shown that translocation of bacteria and their products across the intestinal barrier is a commonplace in patients with liver disease. The deterioration of intestinal barrier integrity and the consulting increased intestinal permeability in cirrhotic patients play a pivotal pathophysiological role in the development of severe complications as high rate of infections, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, variceal bleeding, progression of liver injury and hepatocellular carcinoma. Nevertheless, the exact cellular and molecular mechanisms implicated in the phenomenon of microbial translocation in liver cirrhosis have not been fully elucidated yet.

Entities:  

Keywords:  Bacterial translocation; Cirrhosis; Intestinal bacterial overgrowth; Intestinal barrier; Tight junction

Year:  2015        PMID: 26301048      PMCID: PMC4539399          DOI: 10.4254/wjh.v7.i17.2058

Source DB:  PubMed          Journal:  World J Hepatol


  127 in total

1.  Antibiotic prophylaxis in variceal hemorrhage: timing, effectiveness and Clostridium difficile rates.

Authors:  Matthew R L Brown; Graeme Jones; Kathryn L Nash; Mark Wright; Indra Neil Guha
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.

Authors:  V Lorenzo-Zúñiga; C M Rodríguez-Ortigosa; R Bartolí; M-L Martínez-Chantar; L Martínez-Peralta; A Pardo; I Ojanguren; J Quiroga; R Planas; J Prieto
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

Review 3.  Pathological bacterial translocation in liver cirrhosis.

Authors:  Reiner Wiest; Melissa Lawson; Markus Geuking
Journal:  J Hepatol       Date:  2013-08-28       Impact factor: 25.083

4.  NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.

Authors:  Tony Bruns; Jack Peter; Philipp A Reuken; Dominik H Grabe; Sonja R Schuldes; Julia Brenmoehl; Jürgen Schölmerich; Reiner Wiest; Andreas Stallmach
Journal:  Liver Int       Date:  2011-06-13       Impact factor: 5.828

5.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  Role of mucus in ischemia/reperfusion-induced gastric mucosal injury in rats.

Authors:  J Mojzis; R Hegedüsová; L Mirossay
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

7.  Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study.

Authors:  Ulrich Thalheimer; Fosca De Iorio; Franco Capra; Maria del Mar Lleo; Valeria Zuliani; Valentina Ghidini; Maria Carla Tafi; Greta Caburlotto; Micol Gennari; Andrew K Burroughs; Italo Vantini
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 2.566

8.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 9.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

10.  Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion.

Authors:  F E Tristani; J N Cohn
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more
  18 in total

1.  Quantitative Measure of Intestinal Permeability Using Blue Food Coloring.

Authors:  Stephanie A K Angarita; Sergio Duarte; Tara A Russell; Piotr Ruchala; Irmina A Elliott; Julian P Whitelegge; Ali Zarrinpar
Journal:  J Surg Res       Date:  2018-07-27       Impact factor: 2.192

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

3.  Expression of α-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.

Authors:  Georgios I Tsiaoussis; Eleni C Papaioannou; Eleni P Kourea; Stelios F Assimakopoulos; Georgios I Theocharis; Michalis Petropoulos; Vasileios I Theopistos; Georgia G Diamantopoulou; Zoi Lygerou; Iris Spiliopoulou; Konstantinos C Thomopoulos
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

Review 4.  Gut Barrier and Microbiota in Cirrhosis.

Authors:  Cyriac A Philips; Philip Augustine
Journal:  J Clin Exp Hepatol       Date:  2021-09-03

Review 5.  Inflammatory networks underlying colorectal cancer.

Authors:  Audrey Lasry; Adar Zinger; Yinon Ben-Neriah
Journal:  Nat Immunol       Date:  2016-03       Impact factor: 25.606

Review 6.  Fluid balance concepts in medicine: Principles and practice.

Authors:  Maria-Eleni Roumelioti; Robert H Glew; Zeid J Khitan; Helbert Rondon-Berrios; Christos P Argyropoulos; Deepak Malhotra; Dominic S Raj; Emmanuel I Agaba; Mark Rohrscheib; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2018-01-06

7.  The Role of the Gut Barrier Function in Health and Disease.

Authors:  Stelios F Assimakopoulos; Christos Triantos; Ioannis Maroulis; Charalambos Gogos
Journal:  Gastroenterology Res       Date:  2018-02-08

8.  Escherichia coli Eyelid Abscess in a Patient with Alcoholic Cirrhosis.

Authors:  Matthew Stratton; Cara Capitena; Logan Christensen; Miguel Paciuc-Beja
Journal:  Case Rep Ophthalmol Med       Date:  2015-09-15

9.  Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats.

Authors:  Ding Shi; Longxian Lv; Daiqiong Fang; Wenrui Wu; Chenxia Hu; Lichen Xu; Yanfei Chen; Jing Guo; Xinjun Hu; Ang Li; Feifei Guo; Jianzhong Ye; Yating Li; Dewi Andayani; Lanjuan Li
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 10.  Emergency Management of Spontaneous Bacterial Peritonitis - A Clinical Review.

Authors:  Tracy MacIntosh
Journal:  Cureus       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.